Clinical Trials List
Protocol NumberCA184-162
2012-10-01 - 2015-12-31
Phase II
Terminated2
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Radiology
- Ming-Huang Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
114 participants
